RSSDI Repository, Complications of Diabetes Demonstration RSSDI Repository, Complications of Diabetes Demonstration

Have a Question?

If you have any question you can ask below or enter what you are looking for!

  • Home/
  • Article /
  • Invokana (Canagliflozin) as a dual inhibitor of acetylcholinesterase and sodium glucose co-transporter 2: advancement in Alzheimer's disease- diabetes type 2 linkage via an enzoinformatics study.

Invokana (Canagliflozin) as a dual inhibitor of acetylcholinesterase and sodium glucose co-transporter 2: advancement in Alzheimer's disease- diabetes type 2 linkage via an enzoinformatics study.

Add to Collection
2014 Apr Others Fist_Author_Year_PM

Full Author : ['Rizvi, Syed M D', 'Shakil, Shahnawaz', 'Biswas, Deboshree', 'Shakil, Shazi', 'Shaikh, Sibhghatulla', 'Bagga, Paramdeep', 'Kamal, Mohammad A']
Journal Title : CNS & neurological disorders drug targets
Chapter : Section3
Journal Year : 2014
Cited by : Not Available

Acetylcholinesterase (AChE) is a primary target for Alzheimer's therapy while recently sodium glucose cotransporter 2 (SGLT2) has gained importance as a potential target for Type 2 Diabetes Mellitus (T2DM) therapy. The present study emphasizes the molecul.....

Keywords : ["alzheimer disease diabetes type linkage via", "sodium glucose cotransporter advancement", "invokana canagliflozin", "enzoinformatic study", "dual inhibitor", "acetylcholinesterase"]